{"filing":{"accession_number":"0001493152-26-034815","cik":"0001506983","ticker":"GCTK","company_name":"Glucotrack, Inc.","form":"8-K","filing_date":"2026-07-27","report_date":"2026-07-22","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226034815/form8-k.htm"},"events":[{"id":20729,"run_id":18655,"accession_number":"0001493152-26-034815","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"The filing discloses an Exchange Agreement dated July 22, 2026, under which an investor may exchange a $900,000 promissory note (the \"Partitioned Note\") for shares of common stock at a price determined by recent Nasdaq closing prices. This is a classic convertible debt instrument with an embedded equity conversion feature, structured as an unregistered private placement under Section 4(a)(2) and Section 3(a)(9) of the Securities Act. The disclosure explicitly addresses Item 3.02 (Unregistered Sales of Equity Securities), confirming the dilutive equity issuance component. The beneficial ownership limitation (9.99%) and the mechanics of tranched issuance are typical of dilutive equity raises by smaller public companies.","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-07-27","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":20182,"accession_number":"0001493152-26-034815","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses an Exchange Agreement dated July 22, 2026, under which an investor may exchange a $900,000 promissory note (the \"Partitioned Note\") for shares of common stock at a price determined by recent Nasdaq closing prices. This is a classic convertible debt instrument with an embedded equity conversion feature, structured as an unregistered private placement under Section 4(a)(2) and Section 3(a)(9) of the Securities Act. The disclosure explicitly addresses Item 3.02 (Unregistered Sales of Equity Securities), confirming the dilutive equity issuance component. The beneficial ownership limitation (9.99%) and the mechanics of tranched issuance are typical of dilutive equity raises by smaller public companies.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-27T20:32:00.882637+00:00","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-07-27"}]}